ReviewHealth science reports2026
Integrated HIV and TB Services for the Management of Coinfection in West Africa: A Scoping Review of Strategies, Outcomes, Barriers and Enablers.
Review in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: There is a concern about treatment outcomes for human immunodeficiency virus and tuberculosis infections in West Africa. This has led to a focus on the development of strategies for integrated care; however, data on the barriers and enablers of these strategies are limited. The scoping review aimed to map strategies for the integrated management of HIV and TB services in West Africa and identify barriers and enablers influencing implementation. Methods: The Arksey and O'Malley scoping review design was used for the study. The PRISMA extension for scoping review guidelines were followed meticulously. Four data sources (Scopus, PubMed, MEDLINE and CINAHL) were searched for strategies of integrated management for HIV and TB co-infection in West Africa, from January 1, 2000 to March 31, 2022. Of the 813 records screened, 22 studies met the inclusion criteria. Results: Seven key components were identified: anti-TB therapy (for active co-infection), isoniazid preventive therapy (IPT), tuberculosis infection control (TBIC), antiretroviral therapy (ART) initiation, TB testing, co-trimoxazole preventive therapy (prophylaxis), and patient education/counseling. ART initiation and TB testing showed moderate-to-high success (75%-98% testing rates), while isoniazid preventive therapy (IPT) and TBIC had poor implementation (median IPT score: 0 in Ghana; 0%-42% TBIC adherence). The treatment success rates of the integrated management of HIV and TB co-infection reached 77% in settings with robust integration although mortality remained high (15%-19.5%). Barriers included staff shortages, stigma, inadequate financing, drug shortages, infrastructure gaps and fear of adverse drug interactions. The enablers were patient education, healthcare worker training, optimized logistics and strengthened health information systems. Conclusion: Integration of TB and HIV services was found to be possible in West Africa, with different degrees of effectiveness due to differences in law and local settings. Scaling up requires addressing health system barriers, enhancing training, and leveraging enablers such as patient empowerment and data-driven logistics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.